Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|December 4, 1996

Biosound releases upgrade for AU4

Ultrasound vendor Biosound of Indianapolis will unveil a majorproduct upgrade developed by its parent, Esaote Biomedica of Italy.Introduced as an upgrade for Biosound's high-performance AU4 platform,Advanced Contrast Technology (ACT) incorporates

Ultrasound vendor Biosound of Indianapolis will unveil a majorproduct upgrade developed by its parent, Esaote Biomedica of Italy.Introduced as an upgrade for Biosound's high-performance AU4 platform,Advanced Contrast Technology (ACT) incorporates interactive managementof apodization and dynamic control of beam amplitude to improvecontrast resolution. ACT also provides time-wait processing thatadapts the beam velocity to different tissue impedances. An inexpensiveblack-and-white, color-upgradable version of Biosound's AU3 systemwill also be shown.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.